Cell Signaling Technology

LAP2 alpha (3A3) Mouse Monoclonal Antibody

#5369 · $158

100
Citing papers
13.6k
Combined citations
Supplier page Find this product

Research areas

MicroRNA in disease regulation20Cancer-related molecular mechanisms research13Circular RNAs in diseases11Cancer Cells and Metastasis9Extracellular vesicles in disease8Cancer-related Molecular Pathways6Cytokine Signaling Pathways and Interactions6PI3K/AKT/mTOR signaling in cancer6

Papers citing this product

1
AZD2171: A Highly Potent, Orally Bioavailable, Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor for the Treatment of Cancer
Cancer Research·2005·710 cit.·DOI
2
Coding and noncoding landscape of extracellular RNA released by human glioma stem cells
Nature Communications·2017·549 cit.·DOI
3
Circadian clock proteins regulate neuronal redox homeostasis and neurodegeneration
Journal of Clinical Investigation·2013·532 cit.·DOI
4
YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor‐2 tyrosine kinase with potent activity <i>in vitro</i> and <i>in vivo</i>
Cancer Science·2011·519 cit.·DOI
5
The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo
Genes & Development·2009·509 cit.·DOI
6
MiR-21 Induced Angiogenesis through AKT and ERK Activation and HIF-1α Expression
PLoS ONE·2011·494 cit.·DOI
7
Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer
Experimental & Molecular Medicine·2019·382 cit.·DOI
8
Artemisinins Target GABAA Receptor Signaling and Impair α Cell Identity
Cell·2016·376 cit.·DOI
9
Integrated Genomic Characterization Reveals Novel, Therapeutically Relevant Drug Targets in FGFR and EGFR Pathways in Sporadic Intrahepatic Cholangiocarcinoma
PLoS Genetics·2014·341 cit.·DOI
10
Exosome-mediated breast cancer chemoresistance via miR-155 transfer
Scientific Reports·2018·332 cit.·DOI